academic article

• Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates A?, tau, immunity and lipid processing..  Nature Genetics.  51:414-430. 2019
• Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease..  Nature Genetics.  49:1373-1384. 2017
• A novel Alzheimer disease locus located near the gene encoding tau protein..  Molecular Psychiatry.  21:108-117. 2016
• Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease..  PloS one.  9:e94661. 2014
• Cdk5-mediated phosphorylation of delta-catenin regulates its localization and GluR2-mediated synaptic activity..  The Journal of neuroscience : the official journal of the Society for Neuroscience.  30:8457-8467. 2010
• Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5..  Biotechnology Journal.  2:978-987. 2007
• Calpain mediates calcium-induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer's disease..  American Journal of Pathology.  165:795-805. 2004
• p35/cyclin-dependent kinase 5 phosphorylation of ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent Extracellular Signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons..  The Journal of neuroscience : the official journal of the Society for Neuroscience.  24:4421-4431. 2004
• Neuronal cyclin-dependent kinase 5: role in nervous system function and its specific inhibition by the Cdk5 inhibitory peptide..  BBA - Protein Structure and Molecular Enzymology BBA - Proteins and Proteomics.  1697:143-153. 2004
• Inhibition of neuronal cyclin-dependent kinase-5 by staurosporine and purine analogs is independent of activation by Munc-18..  Neurochemical Research.  21:629-636. 1996